Fonterra looks to a better year ahead

New Zealand's largest company remains positive about the outlook.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Auckland-based Fonterra (ASX: FSF) saw net profit grow to NZ$736 million for the financial year ending 31 July 2013, up 18% on the prior year. The business said drought conditions in New Zealand impacted earnings, which were down 37% on a normalised basis across Australia and New Zealand.

As a whole company earnings were down just 3%, thanks to strong growth in Asia, Africa and the Middle East. The Australian business is undergoing an overhaul to cut costs and develop brands, as it faces up to squeezed margins and an ultra-competitive retail environment.

The company was hit by controversy in August after being forced to globally recall up to 1,000 tonnes of dairy products over contamination fears. Subsequent tests provided the all clear, after New Zealand's worst drought in nearly 70 years, the issue was not what the company needed and its share price suffered.

Total sales fell 6% to NZ$18 billion and the company declared a dividend of NZ 32 cents per share, down 4% on the prior year. Improved climatic conditions over the last few months means milk volumes are currently forecast to grow 5% over the season to 31 May.

Foolish takeaway

Global demand for dairy continues to grow — the milk rush driven by robust demand from Asia, particularly China. With around 85% of its milk output exported, increasing international prices for its product are a strong tailwind. Fonterra is looking to put a testing 2013 behind it and improving prospects make it an attractive investment proposition.

Interested in our #1 dividend-paying stock? Discover The Motley Fool's favourite income idea for 2013-2014 in our brand-new, FREE research report, including a full investment analysis! Simply click here for your FREE copy of "The Motley Fool's Top Dividend Stock for 2013-2014."

More reading


Motley Fool contributor Tom Richardson does not own shares in any of the companies mentioned in this article.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »